WASHINGTON (dpa-AFX) - The biotechnology company Seagen Inc. (SGEN) announced on Tuesday that its stockholders have approved a proposal under which Pfizer will acquire Seagen.
Under the merger agreement, Pfizer will acquire Seagen for $229 per share in cash for a total of $43 billion.
Seagen will file the final, certified voting results in Form 8-K with the SEC. The acquisition is expected to close in late 2023 or early 2024.
Tuesday, the stock closed at $194.01 in regular trading hours, up 0.27% or $0.52 a share, on Nasdaq.
Copyright(c) 2023 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2023 AFX News
